Literature DB >> 23963453

MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.

Adi E Matitau1, Timothy V Gabor, R Montgomery Gill, Michael P Scheid.   

Abstract

MEKK2 (MAP/ERK kinase kinase-2) is a serine/threonine kinase that belongs to the MEKK/STE11 family of MAP kinase kinase kinases (MAP(3)Ks). MEKK2 integrates stress and mitogenic signals to the activation of NF-κB, JNK1/2, p38, and ERK5 pathways. We have found that MEKK2 is regulated through a phosphorylation-dependent association with 14-3-3, a group of adapters that modulate dimerization and association between proteins. We found that MEKK2 was phosphorylated at Thr-283, which resulted in decreased activation loop phosphorylation at Ser-519 and consequently reduced activity. Mechanistically, we found that MEKK2 associated with inactive MEKK2 in the absence of 14-3-3 binding, which led to trans-autophosphorylation of Ser-519. Enforced binding with 14-3-3 reduced Ser-519 trans-autophosphorylation. Expression of T283A MEKK2 within a MEKK2(-/-) background enhanced stress-activated c-Jun N-terminal kinase activity while elevating IL-6 expression, but also reduced ERK activation with a corresponding reduced proliferation rate. These results indicate that Thr-283 phosphorylation is an important regulatory mechanism for MEKK2 activation.

Entities:  

Keywords:  Cell Proliferation; Gene Expression; Jun N-terminal Kinase (JNK); MAP Kinases (MAPKs); MEKK2; Signal Transduction

Mesh:

Substances:

Year:  2013        PMID: 23963453      PMCID: PMC3784737          DOI: 10.1074/jbc.M113.511352

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression.

Authors:  B Su; J Cheng; J Yang; Z Guo
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

2.  Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.

Authors:  K Chayama; P J Papst; T P Garrington; J C Pratt; T Ishizuka; S Webb; S Ganiatsas; L I Zon; W Sun; G L Johnson; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Cell transformation by v-Jun deactivates ERK MAP kinase signalling.

Authors:  Elizabeth J Black; Mark Walker; William Clark; Ann MacLaren; David A F Gillespie
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

4.  MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway.

Authors:  T H Chao; M Hayashi; R I Tapping; Y Kato; J D Lee
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

5.  Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1.

Authors:  Y Shen; R Luche; B Wei; M L Gordon; C D Diltz; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  The essential role of MEKK3 in TNF-induced NF-kappaB activation.

Authors:  J Yang; Y Lin; Z Guo; J Cheng; J Huang; L Deng; W Liao; Z Chen; Z Liu; B Su
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

7.  MEK kinase 2 binds and activates protein kinase C-related kinase 2. Bifurcation of kinase regulatory pathways at the level of an MAPK kinase kinase.

Authors:  W Sun; S Vincent; J Settleman; G L Johnson
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

8.  MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.

Authors:  T P Garrington; T Ishizuka; P J Papst; K Chayama; S Webb; T Yujiri; W Sun; S Sather; D M Russell; S B Gibson; G Keller; E W Gelfand; G L Johnson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

9.  Phosphorylation of MEKK3 at threonine 294 promotes 14-3-3 association to inhibit nuclear factor kappaB activation.

Authors:  Adi E Matitau; Michael P Scheid
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

10.  JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors.

Authors:  Clement M Lee; Djamila Onésime; C Damodara Reddy; N Dhanasekaran; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  8 in total

Review 1.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

2.  14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway.

Authors:  Sung Bin Seo; Je-Jung Lee; Hye Hyeon Yun; Chang-Nim Im; Yong-Sam Kim; Jeong-Heon Ko; Jeong-Hwa Lee
Journal:  Mol Neurobiol       Date:  2017-01-23       Impact factor: 5.590

3.  MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.

Authors:  Ahmed A Mirza; Michael P Kahle; Magdalene Ameka; Edward M Campbell; Bruce D Cuevas
Journal:  Biochim Biophys Acta       Date:  2014-01-31

4.  The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.

Authors:  Xavier Cullere; Eva Plovie; Paul M Bennett; Calum A MacRae; Tanya N Mayadas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-04       Impact factor: 11.205

Review 5.  Dynamic self-guiding analysis of Alzheimer's disease.

Authors:  Alexei Kurakin; Dale E Bredesen
Journal:  Oncotarget       Date:  2015-06-10

6.  Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics.

Authors:  Joanna M Woodcock; Carl Coolen; Katy L Goodwin; Dong Jae Baek; Robert Bittman; Michael S Samuel; Stuart M Pitson; Angel F Lopez
Journal:  Oncotarget       Date:  2015-06-10

7.  SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.

Authors:  Pawel K Mazur; Nicolas Reynoird; Purvesh Khatri; Pascal W T C Jansen; Alex W Wilkinson; Shichong Liu; Olena Barbash; Glenn S Van Aller; Michael Huddleston; Dashyant Dhanak; Peter J Tummino; Ryan G Kruger; Benjamin A Garcia; Atul J Butte; Michiel Vermeulen; Julien Sage; Or Gozani
Journal:  Nature       Date:  2014-05-21       Impact factor: 49.962

8.  miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.

Authors:  Chen-Tian Shen; Zhong-Ling Qiu; Hong-Jun Song; Wei-Jun Wei; Quan-Yong Luo
Journal:  J Exp Clin Cancer Res       Date:  2016-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.